(Alliance News) - Foreign investment in the UK declined last year as funding from the US slipped, new data shows, while the government is ramping up efforts to attract more overseas spending. The UK ...

(Alliance News) - Chariot Ltd on Wednesday said Energean PLC has returned its offshore interests in Morocco to Chariot. The London-based, African-focused company working on energy transition and green ...

(Alliance News) - Vinanz Ltd on Wednesday said it has entered an investment agreement with a "global investment manager" for up to USD4 million bridge funding over two tranches. The British Virgin ...

(Alliance News) - The UK could potentially take more US wood pellets to burn for electricity amid ongoing trade talks, Donald Trump's agriculture secretary has said.

Metals One PLC on Wednesday said it has signed an exclusive term sheet for the acquisition of an exploration lease over the Swales Gold Property in Nevada, US. The London-based metal project developer ...

(Alliance News) - Vistry Group PLC on Wednesday announced a lower forward order book, but noted strengthening demand from the private rented sector market. The Kent, England-based house builder said ...

(Alliance News) - Gamma Communications PLC shares slumped on Wednesday, as it reported continued weakness in the UK market. Gamma shares tumbled 13% to 1,136.92 pence each on Wednesday morning. It has ...

Emmanuel Cau at Barclays commented: "Lower tariffs tail risk means lower recession risk. The US-induced trade war is de-escalating more quickly than we had expected, and the meaningful US-China truce ...

(Alliance News) - Gooch & Housego PLC on Wednesday said it has struck a deal to buy optical systems supplier Global Photonics for USD17.5 million.

The York, England-based housebuilder said the discounted total enterprise value for the sale is around GBP100 million. Persimmon expects the sale to complete within three months. Persimmon will ...

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday.

(Alliance News) - GSK announced on Wednesday that it has agreed with Boston Pharmaceuticals to buy steatotic liver disease medication efimosfermin alfa.